Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abeona Therapeutics Inc shares valued at $9,975 were sold by Vazzano Joseph Walter on Jul 22 ’25. At $6.64 per share, Vazzano Joseph Walter sold 1,502 shares. The insider’s holdings dropped to 477,666 shares worth approximately $3.04 million following the completion of this transaction.
Before that, Silverstein Christine Berni had sold 13,093 shares from its account. In a trade valued at $76,669, the Director traded Abeona Therapeutics Inc shares for $5.86 each. Upon closing the transaction, the insider’s holdings decreased to 13,093 shares, worth approximately $0.77 million.
Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early March. As of July 03, 2024, H.C. Wainwright has initiated its “Buy” rating for ABEO. Earlier on May 30, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for ABEO stock.
Analyzing ABEO Stock Performance
On last trading session, Abeona Therapeutics Inc [NASDAQ: ABEO] plunged -6.32% to $6.37. The stock’s lowest price that day was $6.35, but it reached a high of $6.9282 in the same session. During the last five days, there has been a drop of approximately -4.21%. Over the course of the year, Abeona Therapeutics Inc shares have jumped approximately 27.91%.
Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)
RSI (Relative Strength Index) is 51.27 on the 14-day chart, showing neutral technical sentiment.
Is Abeona Therapeutics Inc subject to short interest?
Stocks of Abeona Therapeutics Inc saw a sharp rise in short interest on 2025-07-15 jumping by 2.02 million shares to 8.48 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 6.46 million shares. A jump of 23.8% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.39 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.39.
Which companies own the most shares of Abeona Therapeutics Inc (ABEO)?
In terms of Abeona Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 164.71% from the previous closing price of $6.8. Analysts anticipate Abeona Therapeutics Inc stock to reach 20 by 2025, with the lowest price target being 16. In spite of this, 2 analysts ranked Abeona Therapeutics Inc stock as Buy at the end of 2025. On November 11, 2020, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and upgraded coverage with a $4.
